During the past decade, Cheng Hsin General Hospital conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 11 clinical trials were completed, i.e. on average, 31.4% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 11 clinical trials were completed. i.e. 47.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cheng Hsin General Hospital" #1 sponsor was "Cheng-Hsin General Hospital" with 9 trials, followed by "Boehringer Ingelheim" with 6 trials sponsored, "National Taipei University of Nursing and Health Sciences" with 4 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Orient Pharma Co., Ltd." with 3 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cheng Hsin General Hospital" #1 collaborator was "Cheng-Hsin General Hospital" with 4 trials as a collaborator, "National Taiwan University" with 2 trials as a collaborator, "ABVC BioPharma, Inc" with 1 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator and "CardioVascular Research Foundation, Korea" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Cheng Hsin General Hospital" are "Atrial Fibrillation" (5 trials), "Depressive Disorder, Major" (3 trials), "Neuromyelitis Optica" (2 trials), "Neuromyelitis Optica Spectrum Disorder" (2 trials) and "Stroke" (2 trials). Many other conditions were trialed in "Cheng Hsin General Hospital" in a lesser frequency.

Most popular intervention types in "Cheng Hsin General Hospital" are "Drug" (27 trials), "Device" (9 trials), "Behavioral" (3 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Edoxaban" (3 trials), "Aticaprant" (2 trials), "Prasugrel" (2 trials) and "1PC002" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cheng Hsin General Hospital" are 40 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Cheng Hsin General Hospital". undefined are not yet recruiting, 12 are recruiting, 4 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 23 completed trials in Cheng Hsin General Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Cheng Hsin General Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 10 trials that are defined as “Not Applicable".